Medical Care Corporation Leads Effort to Provide Early Detection of Alzheimer's Disease
October 31, 2005
IRVINE, Calif., Oct. 31 /PRNewswire/ -- Medical Care Corporation (MCC), a
health care company specializing in the early detection and management of
Alzheimer's disease announced it will donate the use of its clinically
validated MCI Screen during the month of November. In recognition of National
Alzheimer's Disease Awareness Month, physicians will have access to the memory
assessment tool without a fee. The technologically advanced memory test is
the most thoroughly validated clinical tool for early detection of memory loss
due to Alzheimer's disease.
The MCI Screen is a 10-minute, computer based exam which allows
specialists and primary care doctors to detect memory loss due to early
Alzheimer's disease with 97% accuracy. The easy-to-administer test detects
Mild Cognitive Impairment (MCI), a transition stage between the cognitive
changes in normal aging and more severe impairment associated with dementia.
Because MCI is also the first stage of Alzheimer's disease, detecting it can
allow physicians to intervene early to manage the disease effectively.
According to a recent Mayo clinic study, MCI patients have a 60% conversion
rate to AD within six years.
Since the test is quick and noninvasive, it makes screening and early
diagnosis possible for more people with concerns about memory loss. The
computerized test provides the physician with an instant report of the
patients' memory function. Physicians can review the results and, depending
on the outcome, pursue additional diagnostic tests as needed. The U.S.
Preventative Services Task Force recommends cognitive assessment whenever
there is evidence or suspicion of memory loss.
Research confirming the accuracy and sensitivity of the memory test was
published in the Proceedings of the National Academy of Sciences (PNAS) in
March of 2005. The study proved that by applying statistical modeling to the
neuropsychological test battery used by the National Institute of Aging
Disease Research Centers, the accuracy for distinguishing normal aging from
the mildest stage of Alzheimer's disease increased to 97%. This accuracy
surpasses that of other more expensive and invasive evaluation methods. The
statistical model developed by a team lead by Dr. William Rodman Shankle,
M.D., allows doctors to more accurately detect patients with mild cognitive
impairment, a condition which precedes dementia caused by AD.
Study data was collected over the course of 10 years and included 471
subjects. A battery of neuropsychological tests, diagnostic laboratory
testing and imaging studies were used to confirm the stage and diagnosis of
each subject. A copy of the article is available on the company website:
Over 20,000 patients have been evaluated with the MCI Screen by
healthcare professionals in the USA during the past year. Three major
Japanese healthcare companies also began distributing the technology in Japan
earlier this year through licensing agreements with MCC.
Physicians and other health care providers can sign up to use the system
through the company website: http://www.mccare.com. In support of early detection
during National Alzheimer's Awareness month, fees for all new users will be
waved during the month of November.
About Medical Care Corporation:
Medical Care Corporation (MCC) specializes in medical technologies that
enable healthcare providers to deliver improved levels of care in the dementia
field. MCC's electronic Dementia Care System gathers, organizes, and
synthesizes patient and treatment information so that professionals can offer
a "best-practice" level of dementia care.
The MCI Screen, the centerpiece of
MCC's proprietary technologies, is the most sensitive tool available for
detecting early stage memory loss. This highly sensitive test allows
healthcare providers to identify and manage Alzheimer's disease and related
disorders at the earliest stages and use currently approved treatment
modalities more effectively. The company is also a leader in communicating
the value of prevention and early detection to patients and caregivers through
its website and educational materials.
More information about the company is
available at two websites: For Healthcare providers: http://www.mccare.com; For
Patients and Caregivers: http://www.preventad.com.
SOURCE Medical Care Corporation
Web Site: http://www.mccare.com http://www.preventad.com
Be the first to comment on this article!